• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Superiority of glycated albumin over glycated haemoglobin as indicator of glycaemic control and predictor of all-cause mortality in patients with type 2 diabetes mellitus receiving peritoneal dialysis.

作者信息

Miyabe Mizuki, Kurajoh Masafumi, Mori Katsuhito, Okuno Senji, Okada Shigeki, Emoto Masanori, Tsujimoto Yoshihiro, Inaba Masaaki

机构信息

Division of Internal Medicine, Dialysis Center, Inoue Hospital, Osaka, Japan.

Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

出版信息

Ann Clin Biochem. 2019 Nov;56(6):684-691. doi: 10.1177/0004563219873688. Epub 2019 Sep 7.

DOI:10.1177/0004563219873688
PMID:31411048
Abstract
摘要

相似文献

1
Superiority of glycated albumin over glycated haemoglobin as indicator of glycaemic control and predictor of all-cause mortality in patients with type 2 diabetes mellitus receiving peritoneal dialysis.在接受腹膜透析的2型糖尿病患者中，糖化白蛋白作为血糖控制指标和全因死亡率预测指标优于糖化血红蛋白。
Ann Clin Biochem. 2019 Nov;56(6):684-691. doi: 10.1177/0004563219873688. Epub 2019 Sep 7.
2
Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.糖化白蛋白和持续血糖监测在接受血液透析治疗的糖尿病患者中替代糖化血红蛋白的应用
Diabet Med. 2013 Nov;30(11):1388-9. doi: 10.1111/dme.12294.
3
[Insights on glycated albumin].[糖化白蛋白的见解]
Ann Biol Clin (Paris). 2019 Aug 1;77(4):407-414. doi: 10.1684/abc.2019.1466.
4
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.使用连续血糖监测评估慢性肾脏病糖尿病患者的血糖控制标志物。
Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.
5
The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.糖化血红蛋白和白蛋白校正糖化血清蛋白对接受持续性腹膜透析的糖尿病患者死亡率的影响
Perit Dial Int. 2015 Sep-Oct;35(5):566-75. doi: 10.3747/pdi.2014.00011. Epub 2014 Nov 13.
6
Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.糖化血红蛋白（HbA1c）比糖化白蛋白更能反映腹膜透析患者的血糖水平。
Adv Perit Dial. 2014;30:75-82.
7
Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.糖化白蛋白与糖化血红蛋白作为糖尿病血液透析患者血糖指标的比较：影响因素
Saudi J Kidney Dis Transpl. 2013 Mar;24(2):260-73.
8
Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.糖化白蛋白与血红蛋白 A1c 及糖尿病血液透析患者死亡率的关系：一项队列研究。
Nephrol Dial Transplant. 2018 Jul 1;33(7):1150-1158. doi: 10.1093/ndt/gfy014.
9
Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA.使用糖化白蛋白与糖化血红蛋白的比值评估过去一个月的血糖控制情况。
Diabet Med. 2018 Jul;35(7):855-861. doi: 10.1111/dme.13640. Epub 2018 May 2.
10
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.血清糖化白蛋白预测伴糖尿病的透析患者全因死亡率：预测生物标志物的荟萃分析和系统评价。
Acta Diabetol. 2021 Jan;58(1):81-91. doi: 10.1007/s00592-020-01581-x. Epub 2020 Aug 30.

引用本文的文献

1
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring.腹膜透析糖尿病患者的血糖控制：从节约葡萄糖方法到血糖监测
Life (Basel). 2025 May 17;15(5):798. doi: 10.3390/life15050798.
2
Glycated serum proteins and albumin but not glycated albumin show negative correlation with BMI in an overweight/obese, diabetic population from the United States.在美国超重/肥胖的糖尿病患者人群中，糖化血清蛋白和白蛋白与 BMI 呈负相关，而糖化白蛋白则不然。
Clin Biochem. 2023 Oct;120:110654. doi: 10.1016/j.clinbiochem.2023.110654. Epub 2023 Sep 26.
3
Nutritional Status Association With Sarcopenia in Patients Undergoing Maintenance Hemodialysis Assessed by Nutritional Risk Index.
通过营养风险指数评估维持性血液透析患者营养状况与肌肉减少症的关联
Front Nutr. 2022 May 13;9:896427. doi: 10.3389/fnut.2022.896427. eCollection 2022.
4
Association of type 2 diabetes with periodontitis and tooth loss in patients undergoing hemodialysis.糖尿病 2 型与血液透析患者牙周炎和牙齿缺失的关系。
PLoS One. 2022 May 6;17(5):e0267494. doi: 10.1371/journal.pone.0267494. eCollection 2022.
5
Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.黄嘌呤氧化还原酶抑制剂的使用与血液透析患者肌肉减少症和严重肌肉减少症风险降低相关。
Front Med (Lausanne). 2022 Feb 7;9:817578. doi: 10.3389/fmed.2022.817578. eCollection 2022.
6
Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases.糖化白蛋白在糖尿病及肾、脑和心血管代谢疾病诊断与监测中的最新进展
J Clin Med. 2020 Nov 11;9(11):3634. doi: 10.3390/jcm9113634.
7
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.血清糖化白蛋白预测伴糖尿病的透析患者全因死亡率：预测生物标志物的荟萃分析和系统评价。
Acta Diabetol. 2021 Jan;58(1):81-91. doi: 10.1007/s00592-020-01581-x. Epub 2020 Aug 30.